2020 PDA Europe Virtual Conference - Visual Inspection Forum

Online, Online

Become a Sponsor and/or Exhibitor

Dear Colleagues,

On behalf of the Scientific Program Planning Committee and PDA Europe, we would like to invite you to the Visual Inspection Forum to take place on 19-20 October 2020.

This forum will provide a platform to present and discuss new developments in the field of visual inspection. This year we will have a special focus on the use of automated visual inspection technology to meet this critical process need.  Discussion will include both the inspection hardware and software along with the validation strategies necessary to deploy this technology.  

We will also cover the emergence of Deep Learning and key concept associated to this step change like data flow and data integrity. We will also address manual inspection which continues to be the reference method for visual inspection. Also, the holistic VI process will be covered with discussions on control strategies such as AQL and defect trending. Key elements of a basic inspection and sampling process along with special considerations for difficult to inspect parenteral (DIP) products such as lyophilized and biopharmaceutical products, and those in special packing types will be covered. The regulatory and compendial requirements that govern the inspection process will also be discussed. On 20 December 2017, the long-awaited revision to Annex 1 of the EU GMP Guidelines was published. While the currently valid Annex 1 only briefly touches on the important topics of container closure integrity control and visual inspection, this revision contains significantly expanded requirements. The new requirements encourage further discussion of the correct understanding and implementation of visual inspection within the pharmaceutical manufacturing supply chain and provide only one of this year‘s hot topics.

We anticipate a strong agenda of knowledgeable experts in this field along with an exhibition of the latest commercial inspection technology and services.

We look forward to seeing you take part in the 2020 Visual Inspection Forum!

Sincerely,

The Co-Chairs

John Shabushnig, PhD, Insight Pharma Consulting
Romain Veillon,
GSK

Program Highlights

 

The 2020 PDA Europe Visual Inspection Forum will focus on Innovations in Automated Visual Inspection! Join the discussions around new developments in inspection hardware and software, the associated validation strategies as well as the specific regulatory and practical considerations for an effective inspection of the growing number of Cell & Gene Therapy products.

Learn the most recent updates to the European Pharmacopoeia and hear the French Inspectorate ANSM share their main findings regarding visual inspection!

Agenda

Discover What's Happening Each Day
Day 1 19 Oct Day 2 20 Oct
Monday, 19 October

Monday, 19 October 2020

9:00
Welcome and Introduction

Falk Klar, PDA Europe
John Shabushnig, Insight Pharma Consulting, Conference Chair
Romain Veillon, GSK Vaccines, Conference Chair

Opening Plenary: Regulatory Updates
Moderator: Romain Veillon, GSK Vaccines

Visual Inspection of parenteral drug products is a highly regulated activity by Pharmacopeia’s and Health Agencies. This forum will start with a session dedicated to regulatory updates. First, inspection citations and findings will be presented from the perspective of the French Authorities. Then, last updates from both USP and EDQM pharmacopoeias will be presented.

09:15
Visual Inspection: Main Findings from the French Inspectorate (ANSM)

Gabriel Berbari, ANSM

09:45
Update on United States Regulatory and Compendial Expectations for Visual Inspection
John Shabushnig,
Insight Pharma Consulting

10:15
An Update to the European Pharmacopoeia

Hanns-Christian Mahler, LONZA

10:45
Q&A, Discussion

11:15 - 11:45
Coffee Break, Poster Session & Exhibition

Session 1: Particles & Particle Identification
Moderator: Markus Lankers,
MIBIC

Understanding the source and composition of particulate matter provides the necessary substrate for the development of adequate control strategies and comprehensive risk assessments. This session will discuss the development and use of analytical methods to further characterize and subsequently classify particles in injectables. A comprehensive overview on the PDA's Zero Visible Defects Project shows the complexity of particle sources and approaches for the reduction of the particle load in the manufacturing environment. A novel approach to determine the identity of particles will be also part of this session.

11:45
An Update on PDA's Zero Visible Defects Project

Herve Soukiassian, BD
Paul Kinsey, GSK

12:15
Atomic Force Microscopy – Infrared (AFM-IR) a New Tool for Particle Identification and Characterization?

Jonas Hoeg Thygesen, Novo Nordisk

12:45
Q&A, Discussion

13:15 - 14:15
Lunch Break, Poster Session & Exhibition

Session 2: Inspection of Cell Therapy Products and other Difficult to Inspect Products
Moderator: Renaud Janssen,
Datwyler

Whereas the majority of drug products in the meantime are inspectable with well-established techniques, a number of products remain difficult to inspect. This session illustrates the challenges and progress for two types of such products. In addition, an excursion is made to the visual inspection challenges for single-use assemblies in the drug manufacturing process.

14:15
Automatic Inspection of Cell Therapy Products: Challenges and Innovative Methods

Massimo Frasson, Brevetti C.E.A.

14:40
Particulate Detection in the Visual Inspection of Single-Use Assemblies: A Knapp Study

Klaus Wormuth, Sartorius Stedim

15:05
Inspection of Difficult to Inspect Lyophilized and Suspension Products on a Combi Inspection Machine

Soren Meyer, InnoScan

15:30
Q&A, Discussion

15:45 - 16:15
Coffee Break, Poster Session & Exhibition

Session 3: Updates in Automated Visual Inspection
Moderator: Andrea Sardella,
Stevanato Group

Difficult to inspect products can take advantage of latest available technologies and processing concepts to improve the detectability of foreign particulate critical for patient safety. Flexible containers as well as turbid media nowadays have become inspectable thanks to high-resolution sensors and artificial intelligence advanced concepts. It is anyway paramount to develop a proper design of equipment to assess the risks in terms also of occurrence and detectability to not sacrifice productivity and putting in place an effective control strategy to keep under control the risks that even the latest technology cannot mitigate.

16:15
Next Generation Toolbox - a Case Study on Automated Visual Inspection of IV-Bags

Florian Krickl, Vitronic

16:40
The Automated Inspection of Opaque Liquid Vaccines

Gregory Palmer, Leibnitz University Hannover

17:05
Risk-based Control Strategies in Automated Visual Inspection

Bram Keymolen, Eye-Tec

17:30
Q&A, Discussion

18:00
End of Conference Day 1 & Networking Event



Tuesday, 20 October

Tuesday, 20 October2020

9:00
Welcome

John Shabushnig, Insight Pharma Consulting
Romain Veillon, GSK Vaccines

Session 4: Deep Learning & Artificial Intelligence
Moderator: Romain Veillon,
GSK Vaccines

In the years to come, Deep Learning will be a major change for automated visual inspection. This session will cover those changes from the perspectives of regulatory guidance, technology development, validation approaches and new developments in capabilities. After an interactive questionnaire, the new PDA Task Force working on Deep Learning will be showcased. Multiple case studies will be presented to cover process design, validation and false reject reduction. To conclude, a panel discussion will allow rich exchanges on Deep Learning deployment.

09:05
Interactive Exercise: Live Mentimeter Questionnaire

John Shabushnig, Insight Pharma Consulting
Romain Veillon, GSK Vaccines

  • Expectations of Deep Learning and AI
  • Industry Experience with Deep Learning and AI
  • Challenges of Implementation

09:15
Points to Consider for the Use of Deep Learning & AI in Visual Inspection

John Shabushnig, Insight Pharma Consulting
Romain Veillon, GSK Vaccines

09:45
Deep Learning Applied to Automated Vision Inspection and Key Points for Design and Validation

Jose Zanardi, Syntegon Technology

10:15 - 10:45
Coffee Break, Poster Session & Exhibition

Session 5: Deep Learning & Artificial Intelligence, con't
Moderator: Romain Veillon,
GSK Vaccines

10:45
Non-Invasive Ways of Using Deep Learning/AI to Lower True and False Reject Rates in Automated Inspection Systems

Connor Kennedy, MSD

11:10
Use Case: Implementation of Deep Learning into an Existing Automatic Inspection Machine
Christian Scherer, Seidenader
Felix Riehn, Seidenader

11:35
Panel Discussion

12:10 - 13:10
Lunch Break, Poster Session & Exhibition

Session 6: Inspection Standards and their Use in Manual Visual Inspection
Moderator:
John Shabushnig, Insight Pharma Consulting

Well-designed and well-maintained reference standard kits for particles and defects are essential to perform successful inspection operations. Attendees will receive an overview of the complex process of developing a reference standard kit with examples given on the most commonly used containers. Also, an approach to a Probability of Detection Study will be shared. It will be discussed how the findings impact the strategy for Visual Inspection Qualification.

13:00
The Development of Reference Standard Test Kits

Swen Maas, Material Analytischer Service

13:30
Visual Inspection Qualification Strategy Considering Standard Defects and Reject Zone

Matteo Rocchi, Eli Lilly & Company
Valerie Rautureau, Eli Lilly & Company

14:00
Q&A, Discussion

14:30 - 15:00
Coffee Break, Poster Session & Exhibition

Closing: Qualification Aspects of VI Technology
Moderator: John Shabushnig,
Insight Pharma Consulting

This session was designed to address practical considerations faced by those who work in the field of visual inspection and stimulate discussion on future directions to improve inspection results. Validation is required and critical to the successful implementation of AVI. False rejects are a concern with all VI methods and impact both cost and yield as well as confidence in the inspection results.

15:00
Case Study: Qualification of an Automatic Inspection Line for a Parenteral Product

Jonny Parsons, Amgen

15:30
False Rejection: Just a Matter of Cost or a Possible Impact on Batch Quality?

Jean-Michel Tasserit, AVI Consulting

16:00
Conference Summaries by the Chairs
John Shabushnig, Insight Pharma Consulting
Romain Veillon, GSK Vaccines

16:30
Closing Remarks & Farewell
Falk Klar, PDA Europe

Registration

Pricing Options

Standard Registration

Member Price

€1.795

GovernmentMember Only

€900

Health AuthorityMember Only

€900

Early Career ProfessionalMember Only

€900

AcademicMember Only

€900

Non-Member

€2.095

See Qualifying Criteria for Member Types.

ALL PRICES IN EURO (EUR), EXCLUDING VAT.

WAYS TO REGISTER: 1. Online Registration   2. [email protected]

PDA MEMBERS: Please remember to log in before registering If you come from a Governmental or Health Authority Institution or from an Academic Organization, please contact [email protected] before registering.

If you need to apply for a visa to enter the event country, PDA Europe must be informed of this fact at least 4 weeks before the start of the event.

Sponsor information will be available soon

We're currently finalizing our list of sponsors and will share the details shortly.
 

Become a Sponsor and/or Exhibitor

Amplify Your Presence and Reach Your Customers!
Become a Sponsor

Elevate your brand and maximize your exposure by becoming a sponsor at the 2020 PDA Europe Virtual Conference - Visual Inspection Forum! Connect with industry leaders, showcase your products and services, and establish your company as a key player in the field.

Request Information
Become an Exhibitor

Boost your brand and visibility by becoming an exhibitor at the 2020 PDA Europe Virtual Conference - Visual Inspection Forum! Connect with industry influencers, showcase your products and services, and position your company as a key player in the field.

Request Information
Contact Us
Have a question or need assistance?

Send us a message, and our team will get back to you shortly. We're here to help!

Contact

Program Inquiries

Exhibition/Sponsorship Inquiries
Christopher Haertig

Training Course Inquiries
Christopher Haertig

Registration Customer Care